A 150 mg daily dose of venlafaxine (Effexor XR) sits squarely in the middle of the approved range, not at the high end. The FDA-approved range for the extended-release formulation runs from 75 mg to 225 mg per day for depression, which puts 150 mg halfway up and well below the ceiling.
That said, the label range only tells part of the story. Venlafaxine’s pharmacological effects change gradually as the dose increases and in ways that other antidepressants do not.
The 150 mg dose happens to sit at an interesting point in that curve. Understanding why can help you make sense of your treatment plan and what to expect if your prescriber suggests going up or down.
Key Takeaways
150 mg is a mid-range dose, not a high one: For venlafaxine (Effexor XR), the approved range for depression is 75 mg to 225 mg daily. A dose of 150 mg is a common therapeutic dose that many people take long-term without ever going higher.
Venlafaxine changes character as the dose rises: At lower doses, it acts mainly on serotonin pathways. Norepinephrine effects become more prominent as the dose increases, which is part of why side effects like blood pressure changes tend to be dose-related.
Higher is not automatically better: A large dose-response meta-analysis found that venlafaxine’s efficacy rises steeply up to roughly 75 to 150 mg and then increases only modestly above that, while side effect dropouts continue to climb. Talk with your prescriber before assuming a dose increase is the answer.
What is Venlafaxine and How is it Dosed?
Before the number makes sense, it helps to know what the medication is and what the approved ranges actually are.
How Venlafaxine Works
Venlafaxine (brand name Effexor XR) belongs to a class of antidepressants called serotonin-norepinephrine reuptake inhibitors, or SNRIs.
It blocks the reabsorption of both serotonin and norepinephrine into presynaptic neurons (nerve cells), leaving more of each available in the space between nerve cells.
The increased levels of these neurotransmitters stimulate postsynaptic receptor activity over time, which is thought to improve mood, attention, focus, and emotional regulation.
Venlafaxine is FDA-approved to treat major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder, and it is used off-label for a number of other conditions including hot flashes, premenstrual dysphoric disorder (PMDD), PTSD, OCD, migraine prevention, and certain pain syndromes.
The medication comes in two formulations. Effexor XR is the extended-release capsule taken once daily, which is by far the more commonly prescribed version today.
The extended-release capsule gradually delivers the medication throughout the day, which helps maintain steadier blood levels and possibly allows some side effects to be more tolerable.
The older immediate-release tablet is taken two or three times a day and has a somewhat different dosing ceiling.
The Approved Dose Ranges
According to the FDA prescribing information for venlafaxine (Effexor XR), the usual approach for major depressive disorder is to start at 75 mg once daily either in the morning or evening, though some prescribers begin at 37.5 mg for the first several days to ease tolerability before moving up.
Dose increases are made in increments of up to 75 mg per day, at intervals of no less than four days, up to a maximum of 225 mg per day.
For generalized anxiety disorder and panic disorder, the maximum dose is also 225 mg per day. For social anxiety disorder, the labeling recommends using 75 mg per day and notes that higher doses did not produce greater benefit, so the target dose there is lower.
So where does 150 mg land? It is the exact midpoint of the depression range. It is double the standard starting dose and two-thirds of the maximum. For many people, it is the dose treatment eventually settles at.
Where 150 mg Fits in the Venlafaxine Dose Spectrum
Seeing the whole ladder at once makes the position of any single rung clearer.
37.5 mg: A starter or step-up dose, often used for the first week to reduce early nausea. Generally used as a starting or titration dose rather than a long-term therapeutic dose for depression.
75 mg: The standard starting and minimum effective dose for depression. Also the target dose for social anxiety disorder.
150 mg: A common mid-range therapeutic dose. Many people achieve meaningful improvement in symptoms and may continue at this dose.
225 mg: The maximum approved dose for Effexor XR across its indications.
Above 225 mg: Only the immediate-release (IR) formulation has been used at higher doses in certain settings, but this is outside the Effexor XR range and is a specialist decision.
People with hepatic (liver) or renal (kidney) impairment may be given smaller doses by up to 25-50% or more of the standard daily dosing, as venlafaxine is primarily metabolized by the liver and cleared by the kidneys. In some cases, the dosage is individualized based on kidney or liver function.
Why 150 mg is a Meaningful Number
Venlafaxine is distinct among antidepressants in that its pharmacological character gradually shifts as the dose rises. This is not marketing jargon but a well-described property of the drug.
At lower doses, venlafaxine binds far more readily to the serotonin transporter than to the norepinephrine transporter. In practical terms, it behaves a lot like an SSRI at lower doses.
As the dose increases, norepinephrine reuptake inhibition becomes more clinically meaningful. Researchers generally consider doses around 150–225 mg/day to produce clinically meaningful effects on both serotonin and norepinephrine, although the exact dose at which norepinephrine effects become significant varies between individuals and remains an area of ongoing research.
This is part of why 150 mg is often treated as a milestone dose.
It is also the point where the evidence on added benefit starts to flatten. A systematic review and dose-response meta-analysis published in The Lancet Psychiatry pooled fixed-dose trials of SSRIs, venlafaxine, and mirtazapine in major depression.
It found that venlafaxine’s efficacy increased fairly steeply up to around 75 to 150 mg, and more modestly above that.
At the same time, discontinuations due to adverse effects showed clear dose dependency across all the drugs studied.
The authors concluded that for the most commonly used second-generation antidepressants, which include venlafaxine, the lower range of the licensed dose achieves the best balance of efficacy, tolerability, and acceptability.
That does not mean higher doses never help. It means the trade-off changes, and that going up is a decision that should weigh the modest expected gain against the more reliable increase in side effects.
What Side Effects Should You Expect at 150 mg?
Because 150 mg is a mid-range dose, side effects at this level are common but usually manageable. Several are worth understanding specifically.
Blood Pressure Changes
This is the side effect most tied to dose with venlafaxine. Controlled trials have shown increases in both systolic and diastolic blood pressure and sustained hypertension, and the risk rises as the dose goes up.
The prescribing information recommends that blood pressure should ideally be well controlled before starting venlafaxine, and people taking the medication should have regular blood pressure monitoring. A sustained increase would prompt either a dose reduction or discontinuation.
If you are at 150 mg or moving toward it, ask your prescriber how often they want your blood pressure checked. They may recommend checking your blood pressure periodically, either at home or during routine healthcare visits.
Common Side Effects
Nausea is the most frequently reported side effect, particularly in the first two weeks, and it often improves as the body adjusts.
Other common effects include headache, dry mouth, sweating, insomnia or drowsiness, dizziness, constipation, decreased appetite, and sexual side effects such as reduced libido or delayed orgasm.
Taking the capsule with food and at a consistent time each day helps many people with the gastrointestinal effects. If nausea is severe or persistent past the first few weeks, that is worth raising rather than tolerating.
Discontinuation Symptoms
Antidepressant discontinuation syndrome happens when antidepressants, including venlafaxine, are discontinued abruptly.
Venlafaxine is consistently identified in the research as one of the antidepressants most likely to produce discontinuation symptoms when stopped. Its short half-life is the main reason, which means the drug is eliminated faster from the body. This matters at any dose, but it becomes more relevant the higher you go, since the drop in blood levels is greater.
Abrupt discontinuation can lead to severe withdrawal symptoms such as headache, sweating, irritability, tiredness, anxiety, insomnia, tremor, confusion, nausea, vomiting, or diarrhea.
The practical implication is that missing doses matters more with venlafaxine than with other antidepressants. Some people notice symptoms after skipping a single dose. Consistency helps, and so does having a refill plan that does not leave gaps.
Moreover, when discontinuing treatment with venlafaxine, it is important to taper gradually under provider supervision. The FDA label recommends tapering the dose by 75 mg at weekly intervals. In some cases, the tapering may need to be done over several months.
When Might Your Prescriber Increase Above 150 mg?
Moving from 150 mg to 225 mg is a legitimate clinical step in some cases, and there are a few situations where it can come up:
Partial response: You have improved meaningfully but not enough, and you are tolerating the current dose well. This is the clearest case for a trial of a higher dose.
Adequate time has passed: Most prescribers want to see four to eight weeks at a stable therapeutic dose before concluding it is not enough. Increasing too early can mean climbing the dose ladder unnecessarily.
Side effects are tolerable: If you are already dealing with blood pressure changes or difficult side effects at 150 mg, going higher usually amplifies them. However, if your side effects are tolerable and the situation warrants it, your provider may increase the dosage beyond 150 mg.
That said, increasing the dose may not be suitable for everyone, especially since the benefit from a dose increase beyond 150 mg of venlafaxine may be modest compared to the corresponding increase in side effect burden, as the Lancet study showed. Adding therapy, switching medications, or adding an augmenting agent are sometimes better moves than pushing the dose.
If you have questions about whether your current dose is right, a psychiatric provider can review your response and side effects with you. Blossom offers virtual appointments with board-certified psychiatric providers covered by in-network insurance, and you can get started here.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or medication. Never start, stop, or change the dose of a prescribed medication without consulting your prescriber first. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Sources
U.S. Food and Drug Administration. (2022, August). Effexor XR (venlafaxine hydrochloride) extended-release capsules prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020699s112lbl.pdf
Singh D, Saadabadi A. Venlafaxine. [Updated 2024 Feb 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535363/
Fagiolini, A., Cardoner, N., Pirildar, S., et al. (2023). Moving from serotonin to serotonin–norepinephrine enhancement with increasing venlafaxine dose: Clinical implications and strategies for a successful outcome in major depressive disorder. Expert Opinion on Pharmacotherapy, 24(15), 1715–1723. https://www.tandfonline.com/doi/full/10.1080/14656566.2023.2242264#abstract
Psychopharmacology Institute. (n.d.). Venlafaxine guide: Pharmacology, indications, dosing guidelines and adverse effects. https://psychopharmacologyinstitute.com/publication/venlafaxine-guide-pharmacology-indications-dosing-guidelines-and-adverse-effects-2888/
Furukawa, T.A., Cipriani, A., Cowen, P.J., et al. (2019). Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. The Lancet Psychiatry, 6(7), 601-609. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30217-2/fulltext
Lense, X. M., Hiemke, C., Funk, C. S. M., et al. (2024). Venlafaxine's therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis. Psychopharmacology, 241(2), 275–289. https://pmc.ncbi.nlm.nih.gov/articles/PMC10806172/
Henssler, J., Schmidt, Y., Schmidt, U., Schwarzer, et al. (2024). Incidence of antidepressant discontinuation symptoms: A systematic review and meta-analysis. The Lancet Psychiatry, 11(7), 534–544. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00133-0/fulltext
National Institute of Mental Health. (2023, December). Mental health medications. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/topics/mental-health-medications
Sheffler, Z. M., Patel, P., & Abdijadid, S. (2026). Antidepressants. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538182/
